ABSTRACT OBJECTIVES This study aimed to investigate the independent and joint associations between family history of myocardial infarction (FH) and coronary artery calcification (CAC) with incident coronary heart disease (CHD).
most powerful predictors of incident coronary heart disease (CHD) (6) . Contrary to most other novel biomarkers, CAC significantly improves the c statistic and net reclassification when added to traditional risk factor (TRF) models (7) .
Patients with FH are often referred for CAC scanning and have an increased prevalence of CAC (8, 9 ); yet, the significance of FH after CAC values are known is unclear. One possibility is that heritable factors reflected in FH will already be captured as coronary plaque and calcification by adulthood, such that FH provides no additional predictive information beyond CAC values. Alternatively, FH and CAC may be additive in predictive value, just as FH has been shown to be additive with other risk factors (8) . Thus, in a large, populationbased study, we sought to determine the independent and joint effects of FH and CAC on the risk for CHD events.
METHODS
STUDY SAMPLE. The DHS (Dallas Heart Study) is a multiethnic, probability-based, population cohort study in adults in Dallas County, Texas, with deliberate oversampling of African Americans. Detailed methods of DHS phase 1 (DHS-1) have been described previously (10) . All subjects provided written informed consent, and the study protocol was approved by the institu- had incomplete follow-up for nonfatal endpoints (Online Fig. 1 ). The final study population comprised 2,390 participants free of cardiovascular disease and followed up for fatal and nonfatal CHD events.
DEFINITIONS. Race/ethnicity, history of cardiovascular disease, individual medication usage, family history, and smoking status were self-reported.
Detailed definitions of the variables hypertension, metabolic syndrome, and diabetes in the DHS have been previously published (11) . FH was defined as any first-degree relative with a history of myocardial infarction. Family history of premature CHD was defined as myocardial infarction occurring before the age of 50 years in a first-degree male relative or before the age of 55 years in a first-degree female relative, as predetermined in the original DHS questionnaire (8) .
Given the small number of subjects with premature FH, we used the more inclusive definition of any FH for the primary analyses. As part of our subgroup analysis, participants were stratified using prespecified age cutoffs of 45 years of age in men and 55 years in women (12) . This definition was chosen on the basis of prior reports from the DHS, in which FH was a stronger predictor of CAC among younger participants (8).
MEASUREMENTS. Analytical methods for the biomarkers reported in this study have been previously described, including high-sensitivity C-reactive protein (13), highly sensitive troponin T (14) , N-terminal pro-brain natriuretic peptide (15) , and lipoprotein assessment (16) . Glomerular filtration rate was calculated using the Modification of Diet in Renal Disease formula (17) . Homeostasis model assessment of insulin resistance was calculated using the following formula (18): fasting insulin ðmIU=mlÞÂfasting glucose ðmmol=lÞ=22:5
Electron-beam CT measurements of CAC were performed in duplicate, 1 to 2 min apart, on an Imatron 150 XP scanner (Imatron Inc., San Bruno, California).
The 2 CAC scores were determined using the Agatston method and then averaged (19) . Dual-energy x-ray absorptiometry (Delphi scanner, Hologic, and Discovery software version 12.2, Bedford, Massachusetts) was used to measure total body fat (20) . Cardiac and aortic magnetic resonance imaging measurements were performed using a 1.5-T magnetic resonance imaging system (Intera, Philips Medical Systems, Best, the Netherlands). Left ventricular mass, aortic wall thickness, and aortic compliance were calculated according to previously published methods (14, 21) .
CLINICAL OUTCOMES. The primary outcome was a composite of CHD-related death, myocardial infarction, and/or coronary revascularization. All revascularization events (coronary artery bypass surgery and percutaneous revascularization) occurring within the first 3 months of CAC scanning were excluded from the analyses as they could have been driven by the CAC test result. Death events were ascertained through December 31, 2009 , in all subjects in the DHS, using the National Death Index (14) . Greater than 90% of subjects from the initial imaging visit were followed up for nonfatal events with these data sources. Primary records were requested for all suspected cardiovascular events, and these events were each adjudicated separately by 2 cardiologists blinded to CAC assessment and all study variables. to 100, >100 to 400, and >400). The proportional hazards assumption was tested by Schoenfeld residuals. The interaction between FH and CAC was tested by adding a multiplicative variable to the fullyadjusted Cox model. Improvement in discrimination was assessed by comparing the c statistics in models with and without FH and CAC, using the Harrell c statistic, and significance was determined using bootstrapping. Category-free or continuous net reclassification improvement (NRI) was also calculated by bootstrapping (22) . We divided our cohort into 4 mutually exclusive groups on the basis of the presence or absence of CAC and FH. Traditional and novel markers were compared among those 4 groups. Because, after stratification by CAC, participants with and without FH had significant age and sex differences, logistic and linear regression models adjusted for age and sex were used for this analysis. All statistical analyses were performed using the SAS software package version 9.2 (SAS Institute Inc., Cary, North Carolina).
RESULTS
The characteristics of the study population stratified by the presence or absence of FH are displayed in Table 1 . The overall mean age was 44 AE 9 years, 56% of subjects were female, and 48% were African American. Most participants were classified as low risk (<6% 10-year risk) on the basis of the Framingham risk score (80%), and 47% had a CAC score of 0.
FH at any age was reported by 32% of patients, and premature FH was reported by 10%. Participants with a positive FH tended to be older, were more often female, had higher prevalences of hypertension and diabetes, and had a more unfavorable lipid profile. (Fig. 1) . In univariate models, FH carried a hazard ratio (HR) of 3.3 (95% confidence interval (CI): 2.1 to 5.2; p < 0.001) ( Table 2) . In multivariate models adjusted for TRF, FH remained significantly associated with CHD (HR adj : 2.6; 95% CI: 1.6 to 4.2; p < Table 1 Table 3) .
Among those without CAC, however, FH was associated with hypertension, diabetes, and metabolic syndrome, as well as higher triglycerides, total fat mass, and left ventricular mass ( Table 3) .
Among young participants, FH was associated with a higher fully-adjusted HR of CHD (5.1; 95% CI:
1.7 to 15.0) compared with that in older participants (HR adj : 2.0; 95% CI: 1.1 to 3.6; p ¼ 0.007) (Fig. 2) . Point 
model). No interaction was noted between FH and
Framingham risk score (p ¼ 0.480).
DISCUSSION
In a large, population-based cohort, we evaluated the joint effects of FH and CAC on clinical CHD events and report several relevant findings. First, FH was independently associated with incident CHD, and this association was not attenuated after CAC was accounted for. Second, patients with both FH and CAC were at higher CHD risk than were those with each of these characteristics in isolation. Among those without CAC, although overall event rates were low, CHD risk was also higher in patients with FH. Logistic and linear regression models adjusted for age and sex.
HOMA-IR ¼ homeostasis model assessment of insulin resistance; hs-TnT ¼ highly sensitive troponin T; LV ¼ left ventricular; NT-proBNP ¼ N-terminal pro-brain natriuretic peptide; OR ¼ odds ratio; other abbreviations as in Table 1 .
factors reflecting inflammatory and coagulation pathways, resulting in rupture-prone plaques that are not completely reflected by one's extent of coronary atherosclerosis (26) . In addition, calcified plaques in the coronary arteries comprise only a small proportion of the total plaque burden. Genetic factors, particularly in younger populations that are less prone to calcification, may operate to increase the risk for CHD events in ways that are not proportional to calcified coronary plaque burden. In fact, 1 study involving patients undergoing coronary CT angiography revealed that FH was associated with the extent of noncalcified coronary plaque independent of the quantity of calcified plaque (27) . 
R E F E R E N C E S

